Eldecalcitol

Eldecalcitol (ED-71) is an orally active vitamin D3 analogue, inhibits bone resorption and increases bone mineral density. Eldecalcitol (ED-71) displays anti-tumor effect and inhibits cell proliferation, migration and induces apoptosis by suppressing GPx-1.


Cat. No.: EX-A5554	Purity: >98%

	Chemical structure of Eldecalcitol

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
5mg	685	In-stock
10mg	900	In-stock
25mg	1550	In-stock
50mg	2450	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	ED-71
CAS No.	104121-92-8
Purity	>98%
Formula	C30H50O5
Mol Weight	490.715
Color	White to off-white
State	solid powder
Solubility	Soluble in DMSO 3.33 mg/mL
Shelf Life	>3 years if stored properly
Storage	Powder 4°C, protect from light, stored under nitrogen; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Matsumoto T.Osteoporosis Treatment by a New Active Vitamin D3 Compound, Eldecalcitol, in Japan.Curr Osteoporos Rep. 2012 Aug 24. [2]. Huang C, et al. Eldecalcitol Inhibits LPS-Induced NLRP3 Inflammasome-Dependent Pyroptosis in Human Gingival Fibroblasts by Activating the Nrf2/HO-1 Signaling Pathway. Drug Des Devel Ther. 2020 Nov 13;14:4901-4913. [3]. Lu Y, et al. Eldecalcitol inhibits the progression of oral cancer by suppressing the expression of GPx-1. Oral Dis. 2021 Aug 24.
CoA	CoA of Eldecalcitol


		Search